Inventors with similar research interests:
Location History:
- Ft. Washington, PA (US) (1998 - 1999)
- Fort Washington, PA (US) (2000 - 2005)
- South San Francisco, CA (US) (2010)
- Doylestown, PA (US) (2004 - 2011)
- Allendale, NJ (US) (2007 - 2017)
- New York, NY (US) (2014 - 2024)
Company Filing History:
31 out of 4,455 
20 out of 4,770 
20 out of 1,309 
Years Active: 1998-2025
Title: Kathrin Ute Jansen: A Pioneer in Immunogenic Compositions
Introduction
Kathrin Ute Jansen, located in New York, NY, is a prominent inventor with an impressive portfolio of 72 patents to her name. Her work primarily focuses on the field of immunogenic compositions and methods, making significant contributions to vaccine development.
Latest Patents
Jansen's latest patents showcase her innovative approach to immunogenic formulations. One of her notable inventions is related to compositions and methods concerning a mutant toxin. This invention includes an immunogenic composition containing mutant toxins A and B, which feature specific mutations in their glucosyltransferase and cysteine protease domains compared to their wild-type counterparts. These mutant toxins may also incorporate chemically crosslinked amino acids, enhancing their utility in culturing and toxin production.
Another recent patent pertains to immunogenic compositions that include conjugated capsular saccharide antigens. This composition is significant for its applicability to serotypes not present in existing vaccines like PREVNAR® and SYNFLORIX®. The advancements Jansen has made in this area particularly benefit the vaccination of vulnerable populations, such as infants and the elderly, against pneumococcal infections.
Career Highlights
Throughout her career, Kathrin Ute Jansen has demonstrated her commitment to advancing vaccine technology. She has worked with notable companies in the industry, including Pfizer Corporation and Merck & Company, Inc. Her efforts in these organizations have pushed the boundaries of vaccine efficacy and safety.
Collaborations
Jansen has collaborated with prominent scientists in her field, including Annaliesa Sybil Anderson and Mark Edward Ruppen. These collaborations have played a critical role in her research and the development of innovative immunogenic compositions.
Conclusion
Kathrin Ute Jansen is a leading figure in the development of immunogenic compositions, with a robust number of patents and impactful contributions to vaccine technology. Her work not only showcases her inventiveness but also highlights the importance of collaboration in paving the way for new medical advancements.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.